Research trial offers at-home test kit to show risk of ovarian cancer

[WCCO-TV, April 30, 2018] For the first time, there’s an at-home test to show a woman’s risk for ovarian cancer. MAGENTA is a free, nationwide clinical trial for women at risk for breast or ovarian cancer.

Dr. Cheryl Bailey, the chief of gynecologic oncology at Abbott Northwestern Hospital, believes this trial will help those who test positive get the information they need. But she worries those with negative test results will fall through the cracks.

“There is a reason you were getting testing and that’s that there is something in your family history that suggests something is going on we might just not have a name for it yet,” she said.

Share this article